Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia

Table 3

Change in clinical status in patients with TCZ.

Clinical status	Baseline TCZ (%)	Day 14(%)	Day 28(%)
1. Discharged from hospital	0	52.8	80
2. Hospitalization, not requiring supplemental O2	2.4	9.6	3.2
3. Hospitalization, requiring supplemental low-flow O2	38.4	13.6	1.6
4. Hospitalization, requiring NIV and/or high-flow supplemental O2	55.2	12.8	2.4
5. Hospitalization, requiring invasive mechanical ventilation or ECMO	4	9.6	7.2
6. Death	0	1.6	5.6